Trending News

More News >

Education

Personal Finance How To Use TipRanks TipRanks Labs Glossary FAQs

About Us

About TipRanks Contact Us Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire

TOOLS

Technical Analysis Screener

Top Analyst Stocks

Popular

Top Smart Score Stocks

Popular

AI Analyst Top Stocks

Daily Analyst Ratings

Daily Insiders Trades

Dividend Stocks

ETF Center

Top Gainers/losers/active ETFs

Trump Dashboard

New

Dividend Calculator

Options Profit Calculator

Dollar Cost Averaging

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

New

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Analysts

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Mortgages

Loans

Investing & Retirement

Education

About Us

Working with TipRanks

STOCKS

GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)

:GLAXO

GLAXO

GlaxoSmithKline Pharmaceuticals Limited

RESEARCH TOOLSreports

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Ratios

Compare

6 Followers

GlaxoSmithKline Pharmaceuticals Limited Ratios

IN:GLAXO's free cash flow for Q1 2026 was ₹0.64. For the 2026 fiscal year, IN:GLAXO's free cash flow was decreased by ₹ and operating cash flow was ₹0.29. See a summary of the company’s cash flow.

Ratios	TTM	Dec 25	Dec 24	Dec 23	Dec 22
Liquidity Ratios
Current Ratio	1.78	1.79	1.84	1.84	1.88
Quick Ratio	1.46	1.54	1.49	1.49	1.53
Cash Ratio	0.45	0.28	0.04	0.04	0.03
Solvency Ratio	0.51	0.45	0.37	0.37	0.43
Operating Cash Flow Ratio	0.00	0.68	0.38	0.38	0.37
Short-Term Operating Cash Flow Coverage	0.00	0.00	0.00	0.00	11.53
Net Current Asset Value	₹ 10.14B	₹ 12.53B	₹ 10.19B	₹ 10.19B	₹ 9.09B
Leverage Ratios
Debt-to-Assets Ratio	<0.01	<0.01	<0.01	<0.01	<0.01
Debt-to-Equity Ratio	0.02	<0.01	0.01	0.01	<0.01
Debt-to-Capital Ratio	0.02	<0.01	0.01	0.01	<0.01
Long-Term Debt-to-Capital Ratio	0.00	0.00	0.00	0.00	0.00
Financial Leverage Ratio	2.15	2.11	2.00	2.00	1.91
Debt Service Coverage Ratio	57.86	695.68	367.53	367.53	15.40
Interest Coverage Ratio	919.02	1.38K	756.21	756.21	463.64
Debt to Market Cap	<0.01	0.00	0.00	0.00	<0.01
Interest Debt Per Share	2.20	0.66	1.21	1.21	1.02
Net Debt to EBITDA	-0.58	-0.46	-0.05	-0.05	-0.02
Profitability Margins
Gross Profit Margin	58.67%	62.29%	58.75%	58.75%	60.49%
EBIT Margin	31.97%	29.72%	23.77%	23.77%	25.78%
EBITDA Margin	33.23%	30.75%	25.78%	25.78%	27.78%
Operating Profit Margin	39.65%	43.50%	39.52%	39.52%	25.81%
Pretax Profit Margin	35.04%	33.60%	23.71%	23.71%	25.72%
Net Profit Margin	25.76%	24.74%	17.14%	17.14%	18.78%
Continuous Operations Profit Margin	25.76%	24.74%	17.14%	17.14%	18.69%
Net Income Per EBT	73.50%	73.62%	72.28%	72.28%	73.01%
EBT Per EBIT	88.39%	77.25%	60.00%	60.00%	99.67%
Return on Assets (ROA)	26.06%	22.58%	16.59%	16.59%	18.36%
Return on Equity (ROE)	52.46%	47.54%	33.19%	33.19%	35.07%
Return on Capital Employed (ROCE)	73.83%	74.03%	66.95%	66.95%	41.95%
Return on Invested Capital (ROIC)	53.90%	54.32%	48.10%	48.10%	29.68%
Return on Tangible Assets	26.12%	22.65%	16.70%	16.70%	18.55%
Earnings Yield	2.35%	1.96%	1.75%	1.75%	2.72%
Efficiency Ratios
Receivables Turnover	11.14	10.39	9.84	15.50	16.90
Payables Turnover	3.20	2.00	2.27	2.27	3.00
Inventory Turnover	2.86	2.93	2.70	2.70	2.79
Fixed Asset Turnover	12.42	13.21	11.08	11.08	10.32
Asset Turnover	1.01	0.91	0.97	0.97	0.98
Working Capital Turnover Ratio	5.72	2.70	2.82	2.82	2.05
Cash Conversion Cycle	46.19	-23.35	11.31	-2.25	30.74
Days of Sales Outstanding	32.77	35.13	37.11	23.55	21.59
Days of Inventory Outstanding	127.62	124.37	134.97	134.97	130.67
Days of Payables Outstanding	114.20	182.84	160.77	160.77	121.52
Operating Cycle	160.39	159.49	172.08	158.52	152.26
Cash Flow Ratios
Operating Cash Flow Per Share	0.00	76.14	34.36	34.36	28.58
Free Cash Flow Per Share	0.00	74.78	32.51	32.51	25.98
CapEx Per Share	0.00	1.36	1.84	1.84	2.60
Free Cash Flow to Operating Cash Flow	0.00	0.98	0.95	0.95	0.91
Dividend Paid and CapEx Coverage Ratio	0.00	1.67	1.02	1.02	0.31
Capital Expenditure Coverage Ratio	0.00	56.03	18.64	18.64	11.00
Operating Cash Flow Coverage Ratio	0.00	129.64	31.18	31.18	31.16
Operating Cash Flow to Sales Ratio	0.00	0.34	0.17	0.17	0.15
Free Cash Flow Yield	0.00%	2.67%	1.64%	1.64%	1.96%
Valuation Ratios
Price-to-Earnings (P/E) Ratio	42.51	51.09	57.04	57.04	36.75
Price-to-Sales (P/S) Ratio	10.95	12.64	9.78	9.78	6.90
Price-to-Book (P/B) Ratio	23.78	24.29	18.93	18.93	12.89
Price-to-Free Cash Flow (P/FCF) Ratio	0.00	37.41	61.09	61.09	50.98
Price-to-Operating Cash Flow Ratio	0.00	36.74	57.81	57.81	46.35
Price-to-Earnings Growth (PEG) Ratio	82.23	0.89	-16.85	-16.85	0.61
Price-to-Fair Value	23.78	24.29	18.93	18.93	12.89
Enterprise Value Multiple	32.37	40.65	37.87	37.87	24.82
Enterprise Value	398.95B	468.60B	336.04B	336.04B	224.23B
EV to EBITDA	32.37	40.65	37.87	37.87	24.82
EV to Sales	10.76	12.50	9.76	9.76	6.90
EV to Free Cash Flow	0.00	36.99	61.01	61.01	50.94
EV to Operating Cash Flow	0.00	36.33	57.74	57.74	46.31
Tangible Book Value Per Share	100.32	114.40	103.54	103.54	100.78
Shareholders’ Equity Per Share	100.81	115.19	104.93	104.93	102.79
Tax and Other Ratios
Effective Tax Rate	0.26	0.26	0.28	0.28	0.27
Revenue Per Share	218.94	221.32	203.17	203.17	191.95
Net Income Per Share	56.39	54.76	34.83	34.83	36.05
Tax Burden	0.74	0.74	0.72	0.72	0.73
Interest Burden	1.10	1.13	1.00	1.00	1.00
Research & Development to Revenue	<0.01	<0.01	<0.01	<0.01	<0.01
SG&A to Revenue	0.04	0.16	0.01	0.01	<0.01
Stock-Based Compensation to Revenue	0.00	0.00	<0.01	<0.01	<0.01
Income Quality	0.00	1.39	0.99	0.99	0.58

Currency in INR